mhurhangee/patent-ind-claim-en huggingface dataset:
A biometric authentication system comprising: headwear comprising an optical sensor configured to capture a series of images of an area of skin on the face of a user so as to obtain an image signal characteristic of the area of skin imaged in the captured series of images, the optical sensor being configured to compare images of the series of images captured apart in time so as to detect movement of the skin relative to the sensor between those points in time, the series of images being processed to extract at least a velocity of movement of the area of skin being imaged as an image signal characteristic; a data store for storing a data set representing skin characteristics for one or more users the skin characteristics including one or more of: wrinkles, glyphic patterns, pigmentation, hair follicles, sebaceous pores, congenital lesions, sun spots, sun tanning, scars, infections, and inflammation; and a processor configured to: process the image signal in dependence on the stored data set so as to determine a correspondence between the image signal and the skin characteristics of one of the one or more users; and in dependence on the determined correspondence, authenticate the image signal as being associated with that user. headwear comprising an optical sensor configured to capture a series of images of an area of skin on the face of a user so as to obtain an image signal characteristic of the area of skin imaged in the captured series of images, the optical sensor being configured to compare images of the series of images captured apart in time so as to detect movement of the skin relative to the sensor between those points in time, the series of images being processed to extract at least a velocity of movement of the area of skin being imaged as an image signal characteristic; a data store for storing a data set representing skin characteristics for one or more users the skin characteristics including one or more of: wrinkles, glyphic patterns, pigmentation, hair follicles, sebaceous pores, congenital lesions, sun spots, sun tanning, scars, infections, and inflammation; and a processor configured to: process the image signal in dependence on the stored data set so as to determine a correspondence between the image signal and the skin characteristics of one of the one or more users; and in dependence on the determined correspondence, authenticate the image signal as being associated with that user. process the image signal in dependence on the stored data set so as to determine a correspondence between the image signal and the skin characteristics of one of the one or more users; and in dependence on the determined correspondence, authenticate the image signal as being associated with that user.
A rope comprising a core for providing strength to said rope , wherein at least a metal or composite fabric comprising multiple substantially parallel elongated metal elements is provided around said core for protecting said core from impact and cutting, wherein said multiple substantially parallel elongated elements are in the lengthwise warp direction and parallel to the selvage of said metal or composite fabric and held by yarns , characterized in that the diameter of said multiple substantially parallel elongated metal elements is in the range of 0.2 to 5 mm and said multiple substantially parallel elongated metal elements are individually coated with a polymer.
An endoscope and a test fixture for testing the endoscope , the endoscope having a channel , a valve chamber in fluid communication with the channel , a valve member removably positioned within the valve chamber , and a first locking portion , wherein the test fixture comprises: a frame having a first gripping portion ; a valve member analogue extending from said frame , wherein said valve member analogue includes a seal configured to seal at least a portion of the valve chamber following removal of said valve member and insertion of the valve member analogue into the valve chamber; a housing movable relative to said frame , wherein said housing is movable between a locked position and an unlocked position with respect to the frame, wherein said housing comprises a second gripping portion , and wherein said second gripping portion is configured to be moved toward said first gripping portion to position said housing in said unlocked position, and wherein said second gripping portion is configured to be moved away from said first gripping portion to position said housing in said locked position, and wherein said housing comprises a second locking portion configured to engage said first locking portion of the endoscope when said second gripping portion is moved away from said first gripping portion ; and characterised in that the test fixture further comprises a retaining member mounted thereto and configured to hold and retain said valve member analogue to said frame . a frame having a first gripping portion ; a valve member analogue extending from said frame , wherein said valve member analogue includes a seal configured to seal at least a portion of the valve chamber following removal of said valve member and insertion of the valve member analogue into the valve chamber; a housing movable relative to said frame , wherein said housing is movable between a locked position and an unlocked position with respect to the frame, wherein said housing comprises a second gripping portion , and wherein said second gripping portion is configured to be moved toward said first gripping portion to position said housing in said unlocked position, and wherein said second gripping portion is configured to be moved away from said first gripping portion to position said housing in said locked position, and wherein said housing comprises a second locking portion configured to engage said first locking portion of the endoscope when said second gripping portion is moved away from said first gripping portion ; and characterised in that the test fixture further comprises a retaining member mounted thereto and configured to hold and retain said valve member analogue to said frame .
A semiconductor structure , comprising: a semiconductor substrate ; a well region on the semiconductor substrate , having a first conductive type; a radio frequency (RF) circuit , comprising at least one FIN field-effect transistor having a plurality of first fins and a plurality of first polys on the well region , wherein the first polys are perpendicular to the first fins ; a pair of guard rings disposed on respective sides of the RF circuit adjacent to the RF circuit , wherein each of the guard rings comprises a plurality of second fins and a pair of second polys on the well region , wherein the second fins have the first conductive type, wherein the second polys are perpendicular to the second fins ; a first isolation region on the well region directly disposed between the RF circuit and the first guard ring , a second isolation region on the well region , wherein the second isolation region is directly disposed between the RF circuit and the other guard ring ; a first dummy poly arranged between the RF circuit and the first guard ring on the first isolation region ; and a second dummy poly arranged between the RF circuit and the other guard ring on the second isolation region ; wherein the first and second dummy polys are arranged parallel to the first and second polys ; wherein the first and second dummy polys overlap the first and second isolation regions , respectively; wherein the first fins are arranged parallel to the second fins , and wherein the first fins are separated from the second fins by the first and second isolation regions . a semiconductor substrate ; a well region on the semiconductor substrate , having a first conductive type; a radio frequency (RF) circuit , comprising at least one FIN field-effect transistor having a plurality of first fins and a plurality of first polys on the well region , wherein the first polys are perpendicular to the first fins ; a pair of guard rings disposed on respective sides of the RF circuit adjacent to the RF circuit , wherein each of the guard rings comprises a plurality of second fins and a pair of second polys on the well region , wherein the second fins have the first conductive type, wherein the second polys are perpendicular to the second fins ; a first isolation region on the well region directly disposed between the RF circuit and the first guard ring , a second isolation region on the well region , wherein the second isolation region is directly disposed between the RF circuit and the other guard ring ; a first dummy poly arranged between the RF circuit and the first guard ring on the first isolation region ; and a second dummy poly arranged between the RF circuit and the other guard ring on the second isolation region ; wherein the first and second dummy polys are arranged parallel to the first and second polys ; wherein the first and second dummy polys overlap the first and second isolation regions , respectively; wherein the first fins are arranged parallel to the second fins , and wherein the first fins are separated from the second fins by the first and second isolation regions .
An isolated nucleic acid comprising a nucleotide sequence encoding a polypeptide with FVIII activity, wherein the nucleotide sequence comprises at least 95% sequence identity to nucleotides 58-2277 and 2320-4374 of SEQ ID NO: 71.
A medical image processing apparatus , comprising: circuitry configured to: obtain a plurality of first images each having a different pixel shift from a medical imaging device, combine each of the plurality of first images a plurality of times to generate a plurality of second images, wherein each time of the plurality of times that the plurality of first images are combined, a different candidate process is used in the combining, each candidate process generating a high resolution image from an expression having parameters that vary depending on deviation amounts from ideal values of the pixel shift of the first images, select one image from the plurality of second images based on a reference image, and select as an optimal candidate process the candidate process corresponding to the selected image, wherein the selected one image has a higher resolution than any one of the plurality of first images. obtain a plurality of first images each having a different pixel shift from a medical imaging device, combine each of the plurality of first images a plurality of times to generate a plurality of second images, wherein each time of the plurality of times that the plurality of first images are combined, a different candidate process is used in the combining, each candidate process generating a high resolution image from an expression having parameters that vary depending on deviation amounts from ideal values of the pixel shift of the first images, select one image from the plurality of second images based on a reference image, and select as an optimal candidate process the candidate process corresponding to the selected image, wherein the selected one image has a higher resolution than any one of the plurality of first images.
Bogie for a rail vehicle with a primary suspension, with a non-suspended level which comprises a wheel, a wheelset shaft and a wheelset bearing, and also with at least one stepladder for climbing into a driver's cab, characterised in that the stepladder is arranged on the non-suspended level of the bogie.
A method (1500; 1600), at a User Equipment, UE, of positioning the UE comprising: receiving (1510; 1610) positioning assistance data associated with a Transmission Reception Point, TRP, the positioning assistance data including an expected Reference Signal Time difference, RSTD, between a reference cell and the TRP; capturing (1550; 1620), based on at least the expected RSTD, a first portion of reference signals from the TRP, wherein, at the UE, the first portion of the reference signals does not overlap in time with non-reference signals from the reference cell and wherein the reference signals from the TRP comprise both the first portion and a second portion, wherein, at the UE, the second portion overlaps in time with non-reference signals from the reference cell; and determining (1550; 1630) a first Time of Arrival, TOA, of the reference signals from the TRP using only the first portion of the reference signals. receiving (1510; 1610) positioning assistance data associated with a Transmission Reception Point, TRP, the positioning assistance data including an expected Reference Signal Time difference, RSTD, between a reference cell and the TRP; capturing (1550; 1620), based on at least the expected RSTD, a first portion of reference signals from the TRP, wherein, at the UE, the first portion of the reference signals does not overlap in time with non-reference signals from the reference cell and wherein the reference signals from the TRP comprise both the first portion and a second portion, wherein, at the UE, the second portion overlaps in time with non-reference signals from the reference cell; and determining (1550; 1630) a first Time of Arrival, TOA, of the reference signals from the TRP using only the first portion of the reference signals.
A method comprising: transmitting, by a first wireless device to a second wireless device, a first request of a first channel state information, CSI, of a first carrier frequency; and transmitting, by the first wireless device to the second wireless device, a second request of a second CSI of a second carrier frequency, wherein the transmitting the second request is: without having received a report of the first CSI based on the first request; and/or before an expiration of a time duration after the transmitting the first request, wherein the expiration of the time duration is associated with cancellation of reporting the first CSI. transmitting, by a first wireless device to a second wireless device, a first request of a first channel state information, CSI, of a first carrier frequency; and transmitting, by the first wireless device to the second wireless device, a second request of a second CSI of a second carrier frequency, wherein the transmitting the second request is: without having received a report of the first CSI based on the first request; and/or before an expiration of a time duration after the transmitting the first request, wherein the expiration of the time duration is associated with cancellation of reporting the first CSI. without having received a report of the first CSI based on the first request; and/or before an expiration of a time duration after the transmitting the first request, wherein the expiration of the time duration is associated with cancellation of reporting the first CSI.
An intraocular lens system for implantation into a lens capsule of an eye having a capsulorhexis with a perimeter, the system comprising: a. an intraocular primary component having a body, one or more haptics , a center through hole having an inside perimeter, and a recess extending around the inside perimeter, wherein the body defines a continuous ring; and b. an intraocular secondary component having a first tab, a second tab, and an optical body , wherein the first tab is fixed, and the second tab is actuatable between a compressed position and an uncompressed extended position, wherein the second tab is configured to be compressed to the compressed position by a compressive force for delivery of the secondary component into the center through hole of the primary component; and wherein the second tab is configured to elastically expand to the extended position in the recess of the primary component by release of the compressive force; c. wherein the recess is configured to releasably receive and connect to the second tab to form an interlocking connection between the primary component and the secondary component. a. an intraocular primary component having a body, one or more haptics , a center through hole having an inside perimeter, and a recess extending around the inside perimeter, wherein the body defines a continuous ring; and b. an intraocular secondary component having a first tab, a second tab, and an optical body , wherein the first tab is fixed, and the second tab is actuatable between a compressed position and an uncompressed extended position, wherein the second tab is configured to be compressed to the compressed position by a compressive force for delivery of the secondary component into the center through hole of the primary component; and wherein the second tab is configured to elastically expand to the extended position in the recess of the primary component by release of the compressive force; c. wherein the recess is configured to releasably receive and connect to the second tab to form an interlocking connection between the primary component and the secondary component.
A nickel base casting alloy consisting of the composition, by weight percent: 19.0 - 22.5 chromium, 7.0 - 9.5 molybdenum, 2.75 - 4.0 niobium, 1.0 - 1.7 titanium, 0.35 - 1.0 manganese, 0.2 - 1.0 silicon, 0 - 0.03 carbon, 0 - 0.015 phosphorus, 0 - 0.01 sulfur, 0 - 0.35 aluminum, 0 - 13.25 iron, the balance being nickel and incidental impurities.
A system for mixing and dispensing a solution, the system comprising: a body (162; 650; 1012) with a first flow passage extending between a diluent inlet (110; 610; 1020) and an outlet (116; 616; 1026), and a second flow passage extending between a concentrate inlet and the first flow passage; and a container (108; 608; 804; 820; 920) for concentrate, the container (108; 608; 804; 820; 920) including a container valve, wherein moving the body (162; 650; 1012) axially toward the container (108; 608; 804; 820; 920) to seat the body (162; 650; 1012) on the container (108; 608; 804; 820; 920) opens the container valve for a flow of concentrate from the container (108; 608; 804; 820; 920) to the first flow passage via the second flow passage, and wherein moving the body (162; 650; 1012) axially away from the container (108; 608; 804; 820; 920) to unseat the body (162; 650; 1012) from the container (108; 608; 804; 820; 920) closes the container valve to the flow of concentrate, wherein the container (108; 608; 804; 820; 920) includes at least one groove (372; 718; 838; 938), wherein the body (162; 650; 1012) includes at least one attachment arm (104, 106; 604, 606; 1004, 1006), and wherein the at least one attachment arm (104, 106; 604, 606; 1004, 1006) is configured to engage the at least one groove (372; 718; 838; 938) to secure the body (162; 650; 1012) to the container (108; 608; 804; 820; 920). a body (162; 650; 1012) with a first flow passage extending between a diluent inlet (110; 610; 1020) and an outlet (116; 616; 1026), and a second flow passage extending between a concentrate inlet and the first flow passage; and a container (108; 608; 804; 820; 920) for concentrate, the container (108; 608; 804; 820; 920) including a container valve, wherein moving the body (162; 650; 1012) axially toward the container (108; 608; 804; 820; 920) to seat the body (162; 650; 1012) on the container (108; 608; 804; 820; 920) opens the container valve for a flow of concentrate from the container (108; 608; 804; 820; 920) to the first flow passage via the second flow passage, and wherein moving the body (162; 650; 1012) axially away from the container (108; 608; 804; 820; 920) to unseat the body (162; 650; 1012) from the container (108; 608; 804; 820; 920) closes the container valve to the flow of concentrate, wherein the container (108; 608; 804; 820; 920) includes at least one groove (372; 718; 838; 938), wherein the body (162; 650; 1012) includes at least one attachment arm (104, 106; 604, 606; 1004, 1006), and wherein the at least one attachment arm (104, 106; 604, 606; 1004, 1006) is configured to engage the at least one groove (372; 718; 838; 938) to secure the body (162; 650; 1012) to the container (108; 608; 804; 820; 920).
An isolated antibody that binds to HER2, wherein the antibody comprises: (i) (a) HVR-H1 comprising the amino acid sequence of SEQ ID NO:15; (b) HVR-H2 comprising the amino acid sequence of SEQ ID NO:16; (c) HVR-H3 comprising the amino acid sequence of SEQ ID NO:17; (d) HVR-L1 comprising the amino acid sequence of SEQ ID NO:12; (e) HVR-L2 comprising the amino acid sequence of SEQ ID NO:13; and (f) HVR-L3 comprising the amino acid sequence of SEQ ID NO:14, wherein the antibody binds HER2 with a dissociation constant (KD) of ≤ 5 nM as determined by surface plasmon resonance; and/or (ii) a heavy chain variable region comprising the sequence of SEQ ID NO: 11 and a light chain variable region comprising the sequence of SEQ ID NO: 10. (i) (a) HVR-H1 comprising the amino acid sequence of SEQ ID NO:15; (b) HVR-H2 comprising the amino acid sequence of SEQ ID NO:16; (c) HVR-H3 comprising the amino acid sequence of SEQ ID NO:17; (d) HVR-L1 comprising the amino acid sequence of SEQ ID NO:12; (e) HVR-L2 comprising the amino acid sequence of SEQ ID NO:13; and (f) HVR-L3 comprising the amino acid sequence of SEQ ID NO:14, wherein the antibody binds HER2 with a dissociation constant (KD) of ≤ 5 nM as determined by surface plasmon resonance; and/or (ii) a heavy chain variable region comprising the sequence of SEQ ID NO: 11 and a light chain variable region comprising the sequence of SEQ ID NO: 10.
A compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of a gastric cancer or a cancer selected from a cancer of the lung, a cancer of the breast, a cancer of the ovary and a cancer of the head and neck, wherein the compound of formula (I), or a pharmaceutically acceptable salt thereof, is administered to a patient in a daily dose of 100 mg to 450 mg for at least two five-consecutive day cycles, wherein said compound, or a pharmaceutically acceptable salt thereof, is not administered to the patient for a period of 2 days to 3 days between one five-consecutive day cycle and its subsequent five-consecutive day cycle.